Under construction – not a live service

Skip to content

Frontlight Research

Trial site

JSC Inlita (Santaros CTC)

Vilnius, LT-08406, LithuaniaEU-13 widening countryNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Atopic dermatitis (eczema)

Closed trials

Completed
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
NCT04392154· Phase 3· Eli Lilly and Company· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – JSC Inlita (Santaros CTC): trial site – Frontlight Research